Kinetic Dependence of Paramyxovirus Entry Inhibition
نویسندگان
چکیده
منابع مشابه
Kinetic dependence of paramyxovirus entry inhibition.
Peptides derived from conserved heptad repeat (HR) regions of paramyxovirus fusion (F) proteins inhibit viral fusion by interfering with the formation of the fusogenic six-helix bundle structure. Peptide efficacy is affected by the strength of the peptide association with the target virus's complementary HR region. Here, we show that a second basis for peptide efficacy lies in the kinetics of F...
متن کاملEnvelope Protein Dynamics in Paramyxovirus Entry
Paramyxoviruses include major pathogens with significant global health and economic impact. This large family of enveloped RNA viruses infects cells by employing two surface glycoproteins that tightly cooperate to fuse their lipid envelopes with the target cell plasma membrane, an attachment and a fusion (F) protein. Membrane fusion is believed to depend on receptor-induced conformational chang...
متن کاملStructural and Mechanistic Studies of Measles Virus Illuminate Paramyxovirus Entry
Measles virus (MeV), a member of the paramyxovirus family of enveloped RNA viruses and one of the most infectious viral pathogens identified, accounts for major pediatric morbidity and mortality worldwide although coordinated efforts to achieve global measles control are in place. Target cell entry is mediated by two viral envelope glycoproteins, the attachment (H) and fusion (F) proteins, whic...
متن کاملTiming is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry.
The Paramyxoviridae include some of the great and ubiquitous disease-causing viruses of humans and animals. In most paramyxoviruses, two viral membrane glycoproteins, fusion protein (F) and receptor binding protein (HN, H or G) mediate a concerted process of recognition of host cell surface molecules followed by fusion of viral and cellular membranes, resulting in viral nucleocapsid entry into ...
متن کاملParamyxovirus Entry and Targeted Vectors for Cancer Therapy
About a century ago, shortly after viruses were recognized, occasional tumor regressions were documented after natural infections. This observation established the idea of using viruses to fight cancer [1]. Early virotherapy clinical trials based on natural viruses were poorly controlled, but recent ones based on modified viruses are subject to extensive monitoring of viral replication, gene ex...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Virology
سال: 2009
ISSN: 0022-538X,1098-5514
DOI: 10.1128/jvi.00416-09